Projected Income Statement: Roche Holding AG

Forecast Balance Sheet: Roche Holding AG

balance-sheet-analysis-chart ROCHE-HOLDING-AG
Fiscal Period: Dicembre 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 2,505 1,882 18,167 15,584 18,699 15,669 9,516 2,618
Change - -24.87% 865.3% -14.22% 19.99% -16.2% -39.27% -72.49%
Announcement Date 1/30/20 2/4/21 2/3/22 2/2/23 2/1/24 - - -
1CHF in Million
Estimates

Cash Flow Forecast: Roche Holding AG

Fiscal Period: Diciembre 2019 2020 2021 2022 2023 2024 2025 2026
CAPEX 1 3,503 3,528 3,693 3,449 3,742 3,727 3,971 4,129
Change - 0.71% 4.68% -6.61% 8.5% -0.4% 6.54% 3.98%
Free Cash Flow (FCF) 1 16,764 10,943 15,691 13,041 11,288 14,255 15,229 16,157
Change - -34.72% 43.39% -16.89% -13.44% 26.28% 6.83% 6.09%
Announcement Date 1/30/20 2/4/21 2/3/22 2/2/23 2/1/24 - - -
1CHF in Million
Estimates

Forecast Financial Ratios: Roche Holding AG

Fiscal Period: Diciembre 2019 2020 2021 2022 2023 2024 2025 2026

Profitability

        
EBITDA Margin (%) 41.35% 41.63% 39.32% 39.53% 37.43% 38.3% 39.22% 39.46%
EBIT Margin (%) 36.57% 36.93% 34.87% 35.04% 32.77% 34.29% 35.12% 35.91%
EBT Margin (%) 27.03% 30.8% 27.7% 25.8% 23.98% 27.68% 30.07% 30.35%
Net margin (%) 21.96% 24.51% 22.18% 19.63% 19.58% 21.03% 23.09% 23.63%
FCF margin (%) 27.27% 18.76% 24.99% 20.61% 19.22% 23.46% 23.75% 24.28%
FCF / Net Income (%) 124.21% 76.55% 112.64% 104.99% 98.17% 111.56% 102.87% 102.74%

Profitability

        
ROA 21.55% 19.59% 19.09% 18.18% 16.71% 14.4% 15.38% 15.22%
ROE 57.7% 47.99% 56.02% 62.5% 45.73% 44.28% 41.29% 36.97%

Financial Health

        
Leverage (Debt/EBITDA) 0.1x 0.08x 0.74x 0.62x 0.85x 0.67x 0.38x 0.1x
Debt / Free cash flow 0.15x 0.17x 1.16x 1.2x 1.66x 1.1x 0.62x 0.16x

Capital Intensity

        
CAPEX / Current Assets (%) 5.7% 6.05% 5.88% 5.45% 6.37% 6.13% 6.19% 6.2%
CAPEX / EBITDA (%) 13.78% 14.53% 14.96% 13.79% 17.03% 16.02% 15.79% 15.73%
CAPEX / FCF (%) 20.9% 32.24% 23.54% 26.45% 33.15% 26.15% 26.07% 25.56%

Items per share

        
Cash flow per share 1 25.91 21.46 24.39 22.79 20.02 20.45 22.35 24.1
Change - -17.16% 13.64% -6.56% -12.16% 2.15% 9.3% 7.85%
Dividend per Share 1 9 9.1 9.3 9.5 9.6 9.846 10.12 10.38
Change - 1.11% 2.2% 2.15% 1.05% 2.56% 2.74% 2.57%
Book Value Per Share 1 37.9 42.5 28.81 35.03 41.37 45.2 52.8 62.84
Change - 12.14% -32.22% 21.58% 18.12% 9.24% 16.83% 19.01%
EPS 1 15.62 16.52 16.2 15.37 14.31 16.58 19.15 20.42
Change - 5.76% -1.94% -5.12% -6.9% 15.83% 15.52% 6.62%
Nbr of stocks (in thousands) 856,061 854,642 800,952 854,579 798,652 796,789 796,789 796,789
Announcement Date 1/30/20 2/4/21 2/3/22 2/2/23 2/1/24 - - -
1CHF
Estimates
2024 *2025 *
P/E ratio 15.4x 13.3x
PBR 5.63x 4.82x
EV / Sales 3.62x 3.33x
Yield 3.87% 3.97%
More valuation ratios * Estimated data

EPS & Dividend

eps-dividend-chart ROCHE-HOLDING-AG

Year-on-year evolution of the PER

evolution-chart ROCHE-HOLDING-AG

Year-on-year evolution of the Yield

evolution-chart ROCHE-HOLDING-AG
Trading Rating
Investor Rating
ESG Refinitiv
A+
surperformance-ratings-light-chart ROCHE-HOLDING-AGMore Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
18
Last Close Price
254.50CHF
Average target price
303.36CHF
Spread / Average Target
+19.20%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. ROG Stock
  4. Financials Roche Holding AG
Exceptional Extension | BLACK FRIDAY -40% : Unlock Tomorrow's Top Investments with Our Exclusive Subscriber-Only Tools!
d
:
:
BENEFIT NOW